Literature DB >> 11426982

Negative predictive value of human papillomavirus test following conization of the cervix uteri.

S Jain1, C J Tseng, S G Horng, Y K Soong, C C Pao.   

Abstract

OBJECTIVE: The goal of this study was to determine/evaluate the negative predictive value of human papillomavirus (HPV) testing following conization of cervix uteri.
METHODS: A prospective analysis was undertaken on 79 cone biopsies of women with high-grade lesions (cervical intraepithelial neoplasia (CIN) III). HPV testing was performed on cervical smears before and after conization. We correlated the margin status (defined as positive cone margin or endocervical curettage status) and positive conization HPV status with the residual disease in a hysterectomy specimen. A Digene II kit was used to perform HPV testing. HPV detection was done by Hybrid Capture assay.
RESULTS: Of the 79 patients, 47(59.5%) had positive margins after conization. HPV testing was positive in 37 cases (78.7%) and negative in 10 cases (21.3%). Residual disease was found in 31 of 47 (66%) postconization hysterectomy specimens. No residual lesions were found in HPV-negative cases. Of the 32 cases with negative margins following conization, HPV testing was negative in 25 cases (78%) and was positive in 7 cases (22%). Among these 25 cases with negative HPV tests, no residual lesion was detected, and in 7 HPV-positive cases, only one residual lesion was found.
CONCLUSION: HPV testing is potentially an effective tool in predicting residual dysplasia after conization and could potentially assist in the decision between hysterectomy and conservative follow-up in women with CIN III. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11426982     DOI: 10.1006/gyno.2001.6241

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia.

Authors:  Jeong-Yeol Park; Jaeman Bae; Myong Cheol Lim; So Yi Lim; Dong-Ock Lee; Sokbom Kang; Sang-Yoon Park; Byung-Ho Nam; Sang-Soo Seo
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

2.  Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays.

Authors:  Jan Wallace; Bruce A Woda; German Pihan
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

3.  Comparison of two surgical methods for the treatment of CIN: classical LLETZ (large-loop excision of the transformation zone) versus isolated resection of the colposcopic apparent lesion - study protocol for a randomized controlled trial.

Authors:  Theresa M Schwarz; Thomas Kolben; Julia Gallwas; Alexander Crispin; Christian Dannecker
Journal:  Trials       Date:  2015-05-23       Impact factor: 2.279

4.  Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis.

Authors:  Mamiko Onuki; Koji Matsumoto; Manabu Sakurai; Hiroyuki Ochi; Takeo Minaguchi; Toyomi Satoh; Hiroyuki Yoshikawa
Journal:  J Gynecol Oncol       Date:  2015-10-08       Impact factor: 4.401

Review 5.  HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions.

Authors:  Luciano Mariani; Maria Teresa Sandri; Mario Preti; Massimo Origoni; Silvano Costa; Paolo Cristoforoni; Fabio Bottari; Mario Sideri
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

6.  Early human papillomavirus testing predicts residual/recurrent disease after LEEP.

Authors:  Aeli Ryu; Kyehyun Nam; Jeongja Kwak; Jeongsig Kim; Seob Jeon
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.